Corticosteroid use in liver disease patients requires careful monitoring due to altered drug metabolism, which may necessitate dosage adjustments. Liver impairment can lead to increased systemic availability of the drug, raising the risk of toxicity.

In patients with liver disease, corticosteroids must be used cautiously due to potential hepatic metabolism alterations and the risk of exacerbating existing liver complications such as ascites or variceal bleeding.